30/01/2019
Ovarian Cancer Drug Approved For Use In NI
An ovarian cancer drug with the potential to extend the life of patients has been approved for use in Northern Ireland for the first time.
Women will now be able to use niraparib, which is already available through the NHS in England, Scotland and Wales.
An average of 221 cases are diagnosed each year in Northern Ireland, and those with recurring ovarian cancer can make use of the drug.
Niraparib works as a targeted treatment which exploits specific weaknesses in cancer cells, preventing them from repairing themselves.
The drug is expected to improve the quality of life for women suffering from the condition, and will lengthen the time when it is stable and not progressing.
Implementing the recommendations of NICE (the National Institute for Health and Care Excellence), the Department of Health has brought patients in the region in line with those from the rest of the UK.
SDLP Health Spokesperson Mark Durkan welcomed the approval of the life-extending treatment.
"For many years the SDLP have stood shoulder to shoulder with sufferers of cancer and other conditions fighting for fair access to vital medication- for parity with elsewhere in the UK," he explained.
"Access to cancer drugs such as Niraparib should not be based on cost but rather on patient need. I am hopeful this medication can help ease the suffering and improve the lives of many people here, including providing their loved ones with comfort in the knowledge that they are being treated with the most suitable drug for their needs.
"Whilst today's announcement is welcome, it is long overdue. Today we think of all those who campaigned for this civil right and those who would have benefited from it but sadly were not given that chance."
The Foyle MLA continued to call for the restoration of Stormont's power-sharing institutions to ensure the public get change on issues of importance.
"Frustratingly, access to Niraparib and other critical drugs have been delayed in the absence of a Health Minister and a functioning Assembly. As too has the urgent need for the implementation of a cancer strategy. These are the issues we need to get serious on, these are the reasons we need our Executive back up and running. People suffering from cancer cannot afford to wait- the people of Northern Ireland deserve better than to be treated as second class citizens where health is concerned."
(JG/CM)
Women will now be able to use niraparib, which is already available through the NHS in England, Scotland and Wales.
An average of 221 cases are diagnosed each year in Northern Ireland, and those with recurring ovarian cancer can make use of the drug.
Niraparib works as a targeted treatment which exploits specific weaknesses in cancer cells, preventing them from repairing themselves.
The drug is expected to improve the quality of life for women suffering from the condition, and will lengthen the time when it is stable and not progressing.
Implementing the recommendations of NICE (the National Institute for Health and Care Excellence), the Department of Health has brought patients in the region in line with those from the rest of the UK.
SDLP Health Spokesperson Mark Durkan welcomed the approval of the life-extending treatment.
"For many years the SDLP have stood shoulder to shoulder with sufferers of cancer and other conditions fighting for fair access to vital medication- for parity with elsewhere in the UK," he explained.
"Access to cancer drugs such as Niraparib should not be based on cost but rather on patient need. I am hopeful this medication can help ease the suffering and improve the lives of many people here, including providing their loved ones with comfort in the knowledge that they are being treated with the most suitable drug for their needs.
"Whilst today's announcement is welcome, it is long overdue. Today we think of all those who campaigned for this civil right and those who would have benefited from it but sadly were not given that chance."
The Foyle MLA continued to call for the restoration of Stormont's power-sharing institutions to ensure the public get change on issues of importance.
"Frustratingly, access to Niraparib and other critical drugs have been delayed in the absence of a Health Minister and a functioning Assembly. As too has the urgent need for the implementation of a cancer strategy. These are the issues we need to get serious on, these are the reasons we need our Executive back up and running. People suffering from cancer cannot afford to wait- the people of Northern Ireland deserve better than to be treated as second class citizens where health is concerned."
(JG/CM)
Related Northern Ireland News Stories
Click here for the latest headlines.
22 May 2019
NI Cancer Patients May Rise By 60%
The number of new cancer patients in Northern Ireland could rocket by over 60% before 2035 if rigorous action is not taken now, Cancer Focus Northern Ireland has warned.
NI Cancer Patients May Rise By 60%
The number of new cancer patients in Northern Ireland could rocket by over 60% before 2035 if rigorous action is not taken now, Cancer Focus Northern Ireland has warned.
09 September 2011
Yellowhammer Portraits Are Framing Success
Two local cancer charities, the Ulster Cancer Foundation (UCF) and Friends of the Cancer Centre, have announced a unique fundraising initiative - the opportunity to buy a highly collectable piece of art by acclaimed Irish artist, Nicola Russell, while making a significant contribution to the work of both charities.
Yellowhammer Portraits Are Framing Success
Two local cancer charities, the Ulster Cancer Foundation (UCF) and Friends of the Cancer Centre, have announced a unique fundraising initiative - the opportunity to buy a highly collectable piece of art by acclaimed Irish artist, Nicola Russell, while making a significant contribution to the work of both charities.
07 November 2008
UCF Targets Cancer Awareness
The signs and symptoms of Northern Ireland's biggest cancer killer are being highlighted by a local charity this week with the Ulster Cancer Foundation (UCF) using national 'Lung Cancer Awareness Month' as a springboard to target local people.
UCF Targets Cancer Awareness
The signs and symptoms of Northern Ireland's biggest cancer killer are being highlighted by a local charity this week with the Ulster Cancer Foundation (UCF) using national 'Lung Cancer Awareness Month' as a springboard to target local people.
04 February 2020
Symptom Awareness This World Cancer Day
The Public Health Agency (PHA) is highlighting the general signs and symptoms of cancer in a bid to raise awareness and boost outcome rates this World Cancer Day.
Symptom Awareness This World Cancer Day
The Public Health Agency (PHA) is highlighting the general signs and symptoms of cancer in a bid to raise awareness and boost outcome rates this World Cancer Day.
26 October 2007
N I Needs Schoolgirl Cancer Jab
A leading Northern Ireland campaigner on cancer prevention and care has welcomed news of a new vaccine that will be offered to young girls nationally. Arlene Spiers, Chief Executive of the Ulster Cancer Foundation (UCF) commented on the cervical cancer vaccine which has been recommended for an NHS immunisation programme.
N I Needs Schoolgirl Cancer Jab
A leading Northern Ireland campaigner on cancer prevention and care has welcomed news of a new vaccine that will be offered to young girls nationally. Arlene Spiers, Chief Executive of the Ulster Cancer Foundation (UCF) commented on the cervical cancer vaccine which has been recommended for an NHS immunisation programme.
-
Northern Ireland WeatherToday:A showery start with outbreaks most frequent north of Lough Neagh and through the morning, before dwindling during the afternoon as the northwest breezes ease and brighter spells of weak sunshine prosper. Maximum temperature 8 °C.Tonight:A dry night, save for a few light showers around the coasts, with prolonged clear spells and light winds bringing a frosty dawn for many in central and southern parts. Minimum temperature -3 °C.